Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up to 75 percent for people living with diabetes starting in January 2024.
"We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes," said Steve Albers, senior vice president of market access and public affairs at Novo Nordisk, Inc. "Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulins, a responsibility we take seriously."
Earlier this month, rival drugmaker Eli Lilly announced plans to reduce insulin prices by 70 percent and cap patient out-of-pocket costs for insulin at $35 per month.
The Biden administration has put public pressure on drugmakers to make medically necessary insulins more affordable. Novo Nordisk notably did not put a cap on out-of-pocket expenses.
Novo Nordisk will lower the price for four different brands, including NovoLog® and NovoLog® Mix 70/30 by 75 percent and Novolin® and Levemir® by 65 percent.
Amazon said Tuesday it launched a new service that will allow customers to purchase physical products while playing video games or interacting in virtual reality.
Some people have a large single stock position from a company they used to work at... but not everyone knows what to do with it. Gina DeRaimo, SVP, Head of The Options Institute at Cboe Global Markets, joins Cheddar News to break down what you can do with large stock positions.
Professional networking platform LinkedIn says it's laying off more than 700 workers and shuttering its China jobs app, in the latest round of tech industry downsizing.
Tyson Foods suffered a surprise loss in the second quarter, something not since 2009, and cut its sales forecast due to the cost of plant closures and layoffs.
